SHL Telemedicine Ltd American Depositary Shares (SHLT) - Total Assets
Based on the latest financial reports, SHL Telemedicine Ltd American Depositary Shares (SHLT) holds total assets worth $80.76 Million USD as of March 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check SHL Telemedicine Ltd American Depositary (SHLT) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
SHL Telemedicine Ltd American Depositary Shares - Total Assets Trend (2002–2024)
This chart illustrates how SHL Telemedicine Ltd American Depositary Shares's total assets have evolved over time, based on quarterly financial data. Explore SHLT long-term investment intensity to see how much of total assets are deployed in long-term investments.
SHL Telemedicine Ltd American Depositary Shares - Asset Composition Analysis
Current Asset Composition (December 2024)
SHL Telemedicine Ltd American Depositary Shares's total assets of $80.76 Million consist of 34.0% current assets and 66.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 9.5% |
| Accounts Receivable | $7.59 Million | 9.4% |
| Inventory | $1.17 Million | 1.5% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $15.70 Million | 19.4% |
| Goodwill | $19.13 Million | 23.7% |
Asset Composition Trend (2002–2024)
This chart illustrates how SHL Telemedicine Ltd American Depositary Shares's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see SHL Telemedicine Ltd American Depositary stock valuation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: SHL Telemedicine Ltd American Depositary Shares's current assets represent 34.0% of total assets in 2024, a decrease from 47.1% in 2002.
- Cash Position: Cash and equivalents constituted 9.5% of total assets in 2024, down from 17.6% in 2002.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 42.0% of total assets, an increase from 24.0% in 2002.
- Asset Diversification: The largest asset category is goodwill at 23.7% of total assets.
SHL Telemedicine Ltd American Depositary Shares Competitors by Total Assets
Key competitors of SHL Telemedicine Ltd American Depositary Shares based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Waystar Holding Corp. Common Stock
NASDAQ:WAY
|
USA | $5.84 Billion |
|
Oneview Healthcare Plc
AU:ONE
|
Australia | AU$15.49 Million |
|
Forian Inc
NASDAQ:FORA
|
USA | $44.13 Million |
|
CardioComm Solutions Inc.
V:EKG
|
Canada | CA$256.24K |
|
Kovo Healthtech Corp
V:KOVO
|
Canada | CA$6.64 Million |
|
NexgenRX Inc.
V:NXG
|
Canada | CA$39.20 Million |
|
Intrasense
PA:ALINS
|
France | €7.99 Million |
|
FEEDBACK PLC LS-5
F:GZM0
|
Germany | €4.86 Million |
SHL Telemedicine Ltd American Depositary Shares - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.04 | 2.17 | 1.19 |
| Quick Ratio | 0.99 | 1.98 | 1.12 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $931.00K | $17.88 Million | $2.56 Million |
SHL Telemedicine Ltd American Depositary Shares - Advanced Valuation Insights
This section examines the relationship between SHL Telemedicine Ltd American Depositary Shares's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.86 |
| Latest Market Cap to Assets Ratio | 0.42 |
| Asset Growth Rate (YoY) | -28.6% |
| Total Assets | $80.76 Million |
| Market Capitalization | $33.60 Million USD |
Valuation Analysis
Below Book Valuation: The market values SHL Telemedicine Ltd American Depositary Shares's assets below their book value (0.42x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: SHL Telemedicine Ltd American Depositary Shares's assets decreased by 28.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for SHL Telemedicine Ltd American Depositary Shares (2002–2024)
The table below shows the annual total assets of SHL Telemedicine Ltd American Depositary Shares from 2002 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $80.76 Million | -28.56% |
| 2023-12-31 | $113.05 Million | +2.05% |
| 2022-12-31 | $110.78 Million | -14.51% |
| 2021-12-31 | $129.59 Million | +99.94% |
| 2020-12-31 | $64.81 Million | +8.38% |
| 2019-12-31 | $59.80 Million | +7.70% |
| 2018-12-31 | $55.53 Million | -15.23% |
| 2017-12-31 | $65.50 Million | +4.59% |
| 2016-12-31 | $62.63 Million | -15.88% |
| 2015-12-31 | $74.45 Million | -19.18% |
| 2014-12-31 | $92.13 Million | -15.10% |
| 2013-12-31 | $108.52 Million | +8.80% |
| 2012-12-31 | $99.73 Million | -7.82% |
| 2011-12-31 | $108.20 Million | +13.81% |
| 2010-12-31 | $95.06 Million | +9.81% |
| 2009-12-31 | $86.57 Million | +5.80% |
| 2008-12-31 | $81.83 Million | -43.24% |
| 2007-12-31 | $144.16 Million | +12.35% |
| 2006-12-31 | $128.32 Million | -6.59% |
| 2005-12-31 | $137.38 Million | -29.82% |
| 2004-12-31 | $195.74 Million | -0.35% |
| 2003-12-31 | $196.43 Million | -5.51% |
| 2002-12-31 | $207.89 Million | -- |
About SHL Telemedicine Ltd American Depositary Shares
SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. It offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; and Cardio'B, a portable device to transmit a 12-lead ECG. The company als… Read more